
GlaxoSmithKline Pharma Share Price
NSE: GLAXO
|BSE: 500660
|Pharmaceuticals
₹3,227.80
+₹56.40 (1.78%) Last updated on 24 Jun, 2025 | 09:53 ISTGlaxoSmithKline Pharma Overview
Market cap | Open ₹3,186.00 | Prev. Close ₹3,171.40 |
Circuit range ₹3,805.60 - ₹2,537.20 | Day range ₹3,186.00 - ₹3,240.50 | Year range ₹1,921.00 - ₹3,515.70 |
Volume 14,389 | Avg. traded ₹3,216.91 | Revenue (12m) ₹3,749 Crs |
About GlaxoSmithKline Pharma
GlaxoSmithKline Pharmaceuticals Limited is an India-based global healthcare company. The Company is engaged in the business of manufacturing, distributing and trading in pharmaceuticals. The Company has three product areas: vaccines, specialty and general medicine. Its general medicines business has a portfolio of medicines in anti-infectives, pain, vitamins medicine, nutritional, hormones, dermatologicals, respiratory and vaccines for adults and children. The Company's general medicine brands include Augmentin, Calpol, Ceftum, Eltroxin, CCM, Neosporin, Betnovate, Tenovate, T-bact and Physiogel. The Company's vaccine brands include Shingrix Herpes Zoster Vaccine, Infanrix Hexa, Synflorix, Boostrix, Havrix, Menveo, Fluarix Tetra and Varilrix. Its specialty medicine brands include Nucala, Seretide, and Trelegy Ellipta. Trelegy Ellipta, single inhaler triple therapy (SITT) for chronic obstructive pulmonary disease (COPD) patients. The Subsidiary of the Company is Biddle Sawyer Limited.
GlaxoSmithKline Pharma Share Price Chart
Please wait...
GlaxoSmithKline Pharma Key Indicators
P/E ratio 58.18 | P/B ratio 29.81 | ROE 48.92% |
ROCE 66.95% | Dividend yield 1.56% | Debt/Equity ratio |
EPS 54.25 |
Investment Checklist: (4/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Analyst Ratings:
75%
Hold
25%
Sell
0%
This analysis is based on the reviews of 4 experts in the last 7 days
GlaxoSmithKline Pharma Financial Ratios
Operating profit margin32.02% | Net profit margin22.43% |
ROE48.92% | ROA24.97% |
ROCE66.95% |
Quick ratio1.54 | Current ratio1.78 |
Interest coverage950.96 | Asset turnover1.11 |
Debt to Equity0 |
P/E ratio58.18 | P/B ratio29.81 |
EV / EBITDA36.09 | |
Dividend yield1.56% |
Revenue Statement
All values are in ₹ Crores (Cr)
Year | Revenue | Operating Profit | Net Profit |
---|---|---|---|
Mar-25 | ₹3,749.21 | ₹1,323.29 | ₹927.58 |
Mar-24 | ₹3,453.71 | ₹1,031.28 | ₹589.96 |
Mar-23 | ₹3,251.72 | ₹904.95 | ₹607.64 |
Mar-22 | ₹3,278.03 | ₹837.65 | ₹380.77 |
Cash Flow
All values are in ₹ Crores (Cr)
Year | Operating | Investing | Financing |
---|---|---|---|
Mar-25 | ₹-45.8 | ₹-769.42 | |
Mar-24 | ₹-561.50 | ||
Mar-23 | ₹-1543.32 | ||
Mar-22 | ₹-405.51 | ₹-524.24 |
Balance Sheet
All values are in ₹ Crores (Cr)
Period | Total Asset | Total Liability |
---|---|---|
Mar-24 | ₹3,410.31 | ₹1,632.67 |
Mar-23 | ₹3,193.04 | ₹1,451.77 |
Mar-22 | ₹4,520.13 | ₹1,857.17 |
Mar-21 | ₹3,011.52 | ₹1,533.26 |
GlaxoSmithKline Pharma Share Price History
Day | Open | Close | Change % |
---|---|---|---|
23-Jun-25 | ₹3,176.50 | ₹3,171.40 | -1.31% |
20-Jun-25 | ₹3,190.20 | ₹3,213.50 | |
19-Jun-25 | ₹3,250.00 | ₹3,199.20 | -2.65% |
18-Jun-25 | ₹3,240.10 | ₹3,286.40 | |
17-Jun-25 | ₹3,344.00 | ₹3,254.00 | -3.35% |
16-Jun-25 | ₹3,285.70 | ₹3,366.80 | |
13-Jun-25 | ₹3,300.00 | ₹3,295.00 | -0.75% |
12-Jun-25 | ₹3,398.00 | ₹3,320.00 | -1.72% |
Corporate Actions
Dividend • ₹42/share
Ex date 30 May 2025
Dividend • ₹12/share
Ex date 07 Nov 2024
Dividend • ₹32/share
Ex date 31 May 2024
Dividend • ₹32/share
Ex date 30 Jun 2023
Stocks Similar to GlaxoSmithKline Pharma
Stock Name | Price | Change % |
---|---|---|
Abbott India | ₹31,290.00 | +₹240.00 (0.77%) |
Ajanta Pharma | ₹2,566.40 | +₹1.50 (0.06%) |
Alkem Laboratories | ₹4,786.50 | +₹26.50 (0.56%) |
Aurobindo Pharma | ₹1,111.70 | +₹12.00 (1.09%) |
Laurus Labs | ₹670.10 | +₹3.80 (0.57%) |
Lupin | ₹1,949.00 | +₹21.80 (1.13%) |
Pfizer | ₹5,616.50 | -₹23.00 (-0.41%) |
Sanofi India | ₹6,019.50 | -₹7.50 (-0.12%) |
Popular Stocks
Stock Name | Price | Change % |
---|---|---|
HDFC Bank | ₹1,961.10 | +₹12.70 (0.65%) |
Hindustan Unilever | ₹2,284.30 | +₹9.20 (0.40%) |
Infosys | ₹1,589.30 | +₹5.30 (0.33%) |
ITC | ₹416.60 | +₹2.70 (0.65%) |
ITC HOTELS LIMITED | ₹215.39 | +₹3.36 (1.58%) |
JIO FIN SERVICES LTD | ₹301.20 | +₹8.05 (2.75%) |
Reliance | ₹1,463.80 | +₹7.00 (0.48%) |
Tata Motors | ₹679.40 | +₹8.15 (1.21%) |
Tata Power | ₹398.45 | +₹5.45 (1.39%) |
Tata Steel | ₹154.08 | +₹1.65 (1.08%) |
GlaxoSmithKline Pharma News
FAQs on GlaxoSmithKline Pharma
What is the share price of GlaxoSmithKline Pharma today?
GlaxoSmithKline Pharma share price is ₹ 3,227.80 as on 24 Jun, 2025 | 09:53 IST.
What are the high & low stock price of GlaxoSmithKline Pharma today?
GlaxoSmithKline Pharma stock price hit a high of ₹ 3,240.50 and low of ₹ 3,186.00 as on 24 Jun, 2025 | 09:53 IST.
What is the market cap of GlaxoSmithKline Pharma?
The market cap of GlaxoSmithKline Pharma is ₹ 53,725.43 Crores as on 24 Jun, 2025 | 09:53 IST.
What are the the 52-week high and low share prices of GlaxoSmithKline Pharma stock on the NSE?
52-week high stock Price of GlaxoSmithKline Pharma is ₹ 3,515.70 and Low Price is ₹ 1,921.00 as on 24 Jun, 2025 | 09:53 IST.
What are the stock symbols of GlaxoSmithKline Pharma?
The stock symbol of GlaxoSmithKline Pharma is NSE: GLAXO on the NSE, BSE: 500660 on the BSE, and the ISIN is INE159A01016.
Can I buy GlaxoSmithKline Pharma shares on Holidays?
No, shares of GlaxoSmithKline Pharma or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell GlaxoSmithKline Pharma shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of GlaxoSmithKline Pharma?
The PE and PB ratio of GlaxoSmithKline Pharma is 58.18 and 29.81 respectively, as on 24 Jun, 2025 | 09:53 IST.
What are the returns on GlaxoSmithKline Pharma shares?
The historical returns for GlaxoSmithKline Pharma shares are 27.02 for 1 year, 113.06 for 3 year and 134.94 for 5 year.